We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Olin
OLN
$2.64B
| $29.3M | 0.04% |
1,142,831
-5,096
| -0.4% | -$121K |
|
|
BMCH
277
DELISTED
BMC Stock Holdings, Inc
BMCH
| $29.2M | 0.04% |
1,496,291
-5,826
| -0.4% | -$106K |
|
|
FOE
278
DELISTED
Ferro Corporation
FOE
| $29.1M | 0.04% |
2,033,719
-503
| -0% | -$7.14K |
|
279
Mativ Holdings
MATV
$448M
| $28.8M | 0.04% |
633,539
-344,294
| -35% | -$14M |
|
|
WNR
280
DELISTED
Western Refining Inc
WNR
| $28.6M | 0.04% |
754,931
-7,554
| -1% | -$248K |
|
281
Banc of California
BANC
$3.28B
| $28M | 0.04% |
1,611,497
+708,204
| +78% | +$10.9M |
|
282
Morgan Stanley
MS
$337B
| $27.9M | 0.04% |
659,428
+198
| +0% | +$7.49K |
|
283
US Bancorp
USB
$99.6B
| $27.7M | 0.04% |
539,135
+286
| +0.1% | +$13.6K |
|
284
WaFd
WAFD
$2.72B
| $27.1M | 0.04% |
788,014
+7,160
| +0.9% | +$219K |
|
|
BRS
285
DELISTED
Bristow Group, Inc.
BRS
| $26.9M | 0.04% |
1,312,836
-4,562
| -0.3% | -$68.7K |
|
286
Popular Inc
BPOP
$11B
| $26.7M | 0.04% |
609,283
+17,003
| +3% | +$688K |
|
287
Universal Corp
UVV
$1.34B
| $26.4M | 0.03% |
413,565
+52,178
| +14% | +$2.98M |
|
288
FirstCash
FCFS
$8.55B
| $26.3M | 0.03% |
560,393
-2,500
| -0.4% | -$118K |
|
289
Ametek
AME
$55.5B
| $26.3M | 0.03% |
541,848
-104,517
| -16% | -$4.95M |
|
290
Booz Allen Hamilton
BAH
$8.7B
| $26.1M | 0.03% |
723,914
+3,141
| +0.4% | +$106K |
|
|
EVHC
291
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $26M | 0.03% |
+410,148
| New | +$26.8M |
|
292
Kemper
KMPR
$1.7B
| $25.9M | 0.03% |
583,760
+70,500
| +14% | +$2.85M |
|
|
SIX
293
DELISTED
Six Flags Entertainment Corp.
SIX
| $25.6M | 0.03% |
426,980
-2,042,428
| -83% | -$114M |
|
294
Viper Energy
VNOM
$8.81B
| $25.6M | 0.03% |
1,588,877
+63,562
| +4% | +$1M |
|
|
GK
295
DELISTED
G&K Services Inc
GK
| $25.4M | 0.03% |
263,422
+1,463
| +0.6% | +$140K |
|
296
ICF International
ICFI
$1.44B
| $25.3M | 0.03% |
458,600
-332,776
| -42% | -$16.9M |
|
297
Starwood Property Trust
STWD
$6.12B
| $25.3M | 0.03% |
1,151,443
+161,839
| +16% | +$3.57M |
|
298
Insight Enterprises
NSIT
$3.55B
| $25.2M | 0.03% |
622,522
-32
| -0% | -$1.1K |
|
299
Sportsman's Warehouse
SPWH
$43.7M
| $25.1M | 0.03% |
2,675,468
+372,463
| +16% | +$3.53M |
|
300
Kosmos Energy
KOS
$1.56B
| $25.1M | 0.03% |
3,583,310
+267,853
| +8% | +$1.52M |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.